11th Annual Human Genome Meeting
Wednesday May 31, 2006
Between May 31 and June 3, 2006, the 11th Annual Human Genome Meeting (HGM) will take place in Helsinki, Finland. The program will include plenary sessions such as "Plagues and ... Read More
Deaths due to infection after RU-486 use or childbirth
Sunday May 28, 2006
Did you know that 14 women in the U.S. have died due to a rare bacterial infection? Learn more about these women's deaths due to Clostridium sordellii infection after use ... Read More
New scientific journal for rare diseases
Thursday May 25, 2006
On March 1, 2006, the European organization Orphanet launched an open-access, peer-reviewed journal, Orphanet Journal of Rare Diseases. The journal is available free online, and no subscription is required to ... Read More
Chanarin-Dorfman syndrome gene activates fat breakdown
Wednesday May 24, 2006
Since 2001 scientists have known that the gene CGI-58 causes the lipid storage disorder Chanarin-Dorfman syndrome. A research team led by the University of Graz in Austria have found that ... Read More
Cysteamine could be Huntington's disease treatment
Tuesday May 23, 2006
In Huntington's disease (HD), a neurodegenerative disorder, abnormal nerve cell (neuron) death occurs. French researchers at the Institut Curie, Centre National de la Recherche Scientifique (CNRS), and Inserm have shown ... Read More
Ehlers-Danlos Syndrome
Sunday May 21, 2006
May is Ehlers-Danlos Syndrome Awareness Month. It is estimated that as many as 50,000 Americans have some form of this connective tissue disorder, but most do not know it. The ... Read More
Animal studies confirm SCID gene therapy risk
Thursday May 18, 2006
Children born with severe combined immunodeficiency (SCID, known as the "bubble boy" disease) have little natural defense against infection. Researchers in France have used gene therapy to create a cure ... Read More
Neuromuscular disorders conference
Wednesday May 17, 2006
The Imperial College of London is hosting a symposium, "Update in Neuromuscular Disorders," on May 17-19, 2006, in London. Topics to be presented include the use of steroids in Duchenne ... Read More
Cystic fibrosis research uses new tool
Tuesday May 16, 2006
Researchers at the Georgia Institute of Technology are using a new multi-functional sensing tool in their study of adenosine triphospate (ATP) release and its role in cystic fibrosis. The tool ... Read More
Acquired Ichthyosis Vulgaris
Sunday May 14, 2006
The skin disorder ichthyosis, when inherited, is a common disorder. When ichthyosis is acquired due to an underlying disorder, though, it is rare. In both cases the affected skin becomes ... Read More
New bacterium found in chronic granulomatous disease
Thursday May 11, 2006
Individuals with chronic granulomatous disease (CGD), an immune disorder, are vulnerable to many different types of infections. Researchers at the National Institute of Allergy and Infectious Diseases have discovered a ... Read More
Metachromatic leukodystrophy research
Wednesday May 10, 2006
Researchers at the San Raffaele Scientific Institute in Milan, Italy, have been studying metachromatic leukodystrophy (MLD), an inherited neurometabolic disorder which causes loss of myelin around nerves. The researchers transplanted ... Read More
Orphan drug status for Zadaxin, Nexavar
Tuesday May 9, 2006
On March 13, 2006, the U.S. Food and Drug Administration (FDA) approved orphan drug status for a new indication for thymalfasin injection (Zadaxin). Made by SciClone Pharmaceuticals, Zadaxin is being ... Read More
Alport syndrome research in mice
Monday May 8, 2006
There is as yet no known cure for Alport syndrome, a genetic disorder which causes kidney failure and hearing loss. A group of researchers led by Beth Israel Deaconess Medical ... Read More
Osteopetrosis
Sunday May 7, 2006
There are several forms of this inherited bone disorder, ranging from mild to severe. A person with osteopetrosis has brittle, dense bones which break easily.
Orphan status for mitochondrial disease drug
Thursday May 4, 2006
On April 4, 2006, the U.S. Food and Drug Administration (FDA) approved orphan drug status for EPI-A0001 for the treatment of inherited mitochondrial respiratory chain diseases (mitochondrial encephalomyopathies). Made by ... Read More
Effects of untreated juvenile dermatomyositis
Wednesday May 3, 2006
The effects of untreated juvenile dermatomyositis, an inflammatory muscle disease, should be taken into account when determining treatment, according to researchers at Northwestern University in Chicago. They examined 166 children ... Read More
Fibrodysplasia ossificans progressiva gene found
Tuesday May 2, 2006
University of Pennsylvania School of Medicine researchers have found the gene which causes fibrodysplasia ossificans progressiva (FOP), a disorder which causes muscle and soft connective tissue to change into bone. ... Read More
Pompe disease drug receives FDA approval
Monday May 1, 2006
On April 28, 2006, the U.S. Food and Drug Administration (FDA) granted marketing approval for the drug Myozyme (alglucosidase alfa) for treatment of Pompe disease in the United States. Manufactured ... Read More
